GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Baiyao Group Co Ltd (SZSE:000538) » Definitions » Debt-to-Equity

Yunnan Baiyao Group Co (SZSE:000538) Debt-to-Equity : 0.05 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Yunnan Baiyao Group Co Debt-to-Equity?

Yunnan Baiyao Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,798 Mil. Yunnan Baiyao Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥169 Mil. Yunnan Baiyao Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥41,580 Mil. Yunnan Baiyao Group Co's debt to equity for the quarter that ended in Mar. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Yunnan Baiyao Group Co's Debt-to-Equity or its related term are showing as below:

SZSE:000538' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.06   Max: 0.13
Current: 0.05

During the past 13 years, the highest Debt-to-Equity Ratio of Yunnan Baiyao Group Co was 0.13. The lowest was 0.00. And the median was 0.06.

SZSE:000538's Debt-to-Equity is ranked better than
81.32% of 851 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs SZSE:000538: 0.05

Yunnan Baiyao Group Co Debt-to-Equity Historical Data

The historical data trend for Yunnan Baiyao Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunnan Baiyao Group Co Debt-to-Equity Chart

Yunnan Baiyao Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.08 0.05 0.06 0.05

Yunnan Baiyao Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.04 0.05 0.05

Competitive Comparison of Yunnan Baiyao Group Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Yunnan Baiyao Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunnan Baiyao Group Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yunnan Baiyao Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Yunnan Baiyao Group Co's Debt-to-Equity falls into.



Yunnan Baiyao Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Yunnan Baiyao Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Yunnan Baiyao Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunnan Baiyao Group Co  (SZSE:000538) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Yunnan Baiyao Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Yunnan Baiyao Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunnan Baiyao Group Co (SZSE:000538) Business Description

Traded in Other Exchanges
N/A
Address
No. 3686, Baiyao Street, Chancheng District, Yunnan Province, Kunming, CHN, 650500
Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which includes herbal products, daily health products, raw medicine, drug classics and among others.

Yunnan Baiyao Group Co (SZSE:000538) Headlines

No Headlines